MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

PF-06447475

CAS No. : 1527473-33-1

MCE 国际站：PF-06447475

产品活性：PF-06447475是高效，选择性，能透过血脑屏障的 LRRK2 抑制剂，IC₅₀值为3 nM。

研究领域：Autophagy

作用靶点：LRRK2

In Vitro: PF-06447475 inhibits LRRK2 enzyme ａnd LRRK2 in the whole cell assay with IC₅₀s of 3 ａnd 25 nM, respectively. Cells incubated with PF-06447475 alone (0.5, 1, 3 μM) or in the presence of ROT significantly reduces (S935)-LRRK2 kinase phosphorylation to control. PF-06447475 significantly preserves the nucleus morphology ａnd ΔΨm of NLCs exposed to ROT compared to untreated ａnd control. PF-475 significantly diminishes ROT-induced ROS generation to a similar extent to cells exposed to PF-475 alone.

In Vivo: In G2019S+ rats treated with PF-06447475, a significant reduction in microgliosis to levels found in wild-type rats could be observed. The proinflammatory marker MHC-II expressed on myeloid cells but not neurons also appears to be less abundant in confocal sections in G2019S+ rats treated with PF-06447475. PF-06447475 treatment in G2019S+ rats significantly lowers the number of CD68 cells recruited to the SNpc. PF-06447475 successfully blocks the enhanced neuroinflammation associated with G2019S-LRRK2 expression. Treatment of G2019S+ rats with PF-06447475 preserves TH expression in the dorsal striatum, consistent with drug attenuating neurodegeneration in the SNpc. PF-06447475 is well tolerated in rats.

相关产品：Bioactive Compound Library Plus | Kinase Inhibitor Library | CNS-Penetrant Compound Library | Autophagy Compound Library | Anti-Parkinson＇s Disease Compound Library | Neurodegenerative Disease-related Compound Library | MLi-2 | IKK 16 | PFE-360 | GNE⁻⁷915 | GNE0877 | LRRK2-IN-1 | HG-10-102-01 | GSK2578215A | GNE-9605 | CZC-54252 | JH-II-127 | CZC-25146 | LRRK2 inhibitor 1

品牌介绍:
• MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供最新最全的高品质小分子活性化合物；
• 10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
• 设有专业的实验中心和严格的质控、验证体系；
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
• 产品的生物活性多经各国客户实验验证；
• Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果；
• 专业团队跟踪最新的制药及生命科学研究进展，为您提供全球最新的活性化合物；
• 与世界各大制药公司及知名科研机构建立了长期的合作。